Cite

HARVARD Citation

    Compte, M. et al. (2018). A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity. Nature communications. 9 (1), pp. 1-13. [Online]. 
  
Back to record